Purchases and Sales Made in Q4 2024 in Stoke Therapeutics, Inc. (STOK)
This table provides information about the institutional ownership of Stoke Therapeutics, Inc. (STOK) during Q4 2024. The information is specifically focused on institutions that hold shares of Stoke Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-173K- 40.5% |
$1.87M - $2.41M
|
254K
$1.83M
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-318K- 96.38% |
$3.44M - $4.43M
|
12K
$86.4K
|
|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-719K- 43.05% |
$7.77M - $10M
|
951K
$6.86M
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-768K- 18.26% |
$8.3M - $10.7M
|
3.44M
$24.8M
|
|
|
Feb 05, 2025
Q4 2024
|
Skorpios Trust
|
SELL
|
- |
-2M- 22.46% |
$21.6M - $27.8M
|
6.91M
$49.8M
|